- $94.03m
- -$76.77m
- 11
- 45
- 33
- 20
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 91.4 | 157 | 270 | 322 | 196 |
Operating Profit | -91.4 | -157 | -270 | -322 | -196 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -85.4 | -153 | -270 | -320 | -186 |
Provision for Income Taxes | |||||
Net Income After Taxes | -85.4 | -153 | -270 | -320 | -186 |
Net Income Before Extraordinary Items | |||||
Net Income | -85.4 | -153 | -270 | -320 | -186 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -85.4 | -153 | -270 | -320 | -186 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.89 | -3.1 | -5.05 | -5.06 | -2.14 |